In a significant move strengthening its technological capabilities, AstraZeneca has appointed Arm Holdings Chief Executive Rene Haas to its board as a non-executive director, effective from next month. The appointment
Pharmaceutical12- Page
206Articles
Artificial intelligence is revolutionising pharmaceutical research, offering groundbreaking opportunities for drug discovery whilst potentially saving billions in development costs. Leading pharmaceutical giants GSK and AstraZeneca are at the forefront of
In a significant development for medical research, UK scientists are pioneering a revolutionary approach to treating rare genetic diseases through a £50 million initiative backed by the Medical Research Council.
Groundbreaking research indicates that popular weight-loss medications like Ozempic, Wegovy, and Mounjaro might have far-reaching applications beyond obesity treatment, potentially revolutionising the approach to various chronic conditions. Dr Mo Sarhan,
The US pharmacy giant Walgreens Boots Alliance has entered discussions regarding a potential sale to private equity firm Sycamore Partners, highlighting the increasing challenges confronting the retail pharmacy sector. The
The pharmaceutical industry has witnessed a dramatic decline in deal activity, reaching its lowest point in nearly a decade as major drugmakers pivot away from commercially ready medicines towards early-stage
A significant move in the pharmaceutical investment landscape has emerged as Carlyle-backed Abingworth seeks to raise up to £1.5 billion for clinical trials funding, marking a strategic shift towards royalty-based
AstraZeneca’s chief executive, Sir Pascal Soriot, has disclosed that former employees in China breached company protocols by using WeChat messaging services, amidst ongoing investigations by Chinese authorities. The revelation comes
Danish pharmaceutical giant Novo Nordisk has reported exceptional third-quarter results, driven by remarkable sales of its weight-loss treatment Wegovy. The anti-obesity medication generated sales of 17.3 billion Danish krone (£1.96
In a significant development for the global pharmaceutical sector, AstraZeneca’s leading executive in China, Leon Wang, has been detained by Chinese authorities, marking an escalation in the ongoing probe into
AstraZeneca, one of the world's leading pharmaceutical companies, experienced a significant setback on Tuesday as its stock price plummeted, wiping out £15 billion in market value. This dramatic drop was triggered by a combination of disappointing early data on its weight loss drug candidate and reports of a major fraud case involving company executives in China. Let's delve into the details of these developments and their potential implications for AstraZeneca's future.
Recent breakthrough research from Denmark’s Aarhus University has sparked significant market interest in the pharmaceutical sector, particularly concerning exercise mimetics. The discovery of LaKe, a compound purported to replicate the
A concerning trend in cancer diagnoses among young adults has sparked a significant £20 million global research initiative. Data from the UK reveals cancer cases in individuals under 50 are
British pharmaceutical giant GSK has held firm on its annual group forecasts despite experiencing a decline in vaccine sales, with strong performance in specialist medicines helping to offset the downturn.
A revolutionary combination of three drugs has demonstrated remarkable success in doubling survival times for patients battling incurable breast cancer, according to a landmark clinical trial. The research, spearheaded by
The French government warned a US-based private equity firm that was buying the consumer healthcare division of Sanofi, that it would face penalties exceeding EUR100m for not keeping production and